Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07010159 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

Study acronym: PASTORALE
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 62 to 63v16
  2. Enrollment increased: 165 → 325 participantsv15 Show 4 more changesShow less
    • Trial sites expanded: 58 → 62 locations
    • Secondary endpoints: 30 to 29
    • Study description revised
    • Study title expanded, about 7 words
  3. Study sites: 56 to 58v14
  4. Trial sites expanded: 52 → 56 locationsv13
  5. Study sites: 50 to 52v12
  6. Trial sites expanded: 46 → 50 locationsv11
  7. Trial sites expanded: 34 → 46 locationsv10
  8. Study sites: 30 to 34v9
  9. Study sites: 23 to 30v8
  10. Study sites: 21 to 23v7
  11. Study sites: 14 to 21v6
  12. Study sites: 7 to 14v5
  13. Study sites: 4 to 7
    • Start date changed from estimate of Oct 31, 2025 to Jul 25, 2025
    v4
  14. Start date: Jul 31, 2025 to Oct 31, 2025
    • Study sites: 1 to 4
    v3
  15. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  16. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
Trial Details
NCT Number NCT07010159
Lead Sponsor Kiniksa Pharmaceuticals International, plc
Collaborators: Kiniksa Pharmaceuticals, GmbH
Conditions
(from sponsor)		 Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Related terms Pericarditis, Recurrence
Enrollment 325 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov